Home

Pacific Biosciences of California, Inc. - Common Stock (PACB)

1.5700
-0.0300 (-1.88%)

Pacific Biosciences is a biotechnology company that specializes in developing advanced sequencing technologies designed to enable detailed analysis of genetic material

The company's innovative platforms are used for applications such as genomics research, clinical diagnostics, and personalized medicine, providing researchers and healthcare professionals with powerful tools for understanding complex biological systems. Their technology focuses on real-time, high-fidelity sequencing, allowing for the detection of genetic variations that traditional methods may miss, thereby contributing to significant advancements in the fields of genomics and molecular biology.

SummaryNewsPress ReleasesChartHistoricalFAQ
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosciences of California, Inc. (“PacBio” or “the Company”) (NASDAQPACB) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · August 2, 2024
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
Via MarketBeat · July 16, 2024
Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research Professionals
Via ACCESSWIRE · June 27, 2024
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms
By GeneDx Holdings Corp.; PacBio · Via GlobeNewswire · August 7, 2023
Pacific Biosciences (NASDAQ: PACB) Making Surprising Moves in Friday Session
Pacific Biosciences Of California, Inc. (NASDAQPACB) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 16.04% on the day to $11.32.
Via Investor Brand Network · March 31, 2023
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force (USPSTF) and from the US Food and Drug Administration are ensuring benefits realized by all—all by moving up the starting screening age of adults […]
Via FinancialNewsMedia · November 11, 2021